Wezlana 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FAUTW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,847
Award facts
- Contract value 100% obligated
- $12,846.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract award ID is SPE2DB24D2106|SPE2DB25FAUTW, with a ceiling value of $12,846.80. It is a firm fixed-price delivery order contract for the supply of a pharmaceutical product, WEZLANA 90 MG/ML SYRINGEML. The contract has an ultimate completion date of March 13, 2025.
DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a diverse array of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This contract award is not associated with a specific set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.
In addition to this delivery order, DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.
Quick answers
Who was awarded contract SPE2DB25FAUTW?
SPE2DB25FAUTW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 12, 2025.
How much is contract SPE2DB25FAUTW worth?
The government has obligated $12,847 on SPE2DB25FAUTW.
Is contract SPE2DB25FAUTW an order under another contract?
Yes. SPE2DB25FAUTW is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAUTW competed?
The extent of competition for SPE2DB25FAUTW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award